BIOMAT Database Logo BIOMAT Database Logo

Inhaled loxapine reduces acute agitation in people with schizophrenia compared with placebo. 2011

Glenn W Currier
School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, New York, USA.

UI MeSH Term Description Entries

Related Publications

Glenn W Currier
Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine.
January 2011, The British journal of psychiatry : the journal of mental science,
Glenn W Currier
Inhaled loxapine (Adasuve) for acute agitation.
April 2014, The Medical letter on drugs and therapeutics,
Glenn W Currier
Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder.
March 2011, International journal of clinical practice,
Glenn W Currier
Inhaled loxapine for the urgent treatment of acute agitation associated with schizophrenia or bipolar disorder.
July 2016, Current medical research and opinion,
Glenn W Currier
Inhaled loxapine for acute agitation in a psychiatric emergency service.
August 2021, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists,
Glenn W Currier
Inhaled loxapine: a new treatment for agitation in schizophrenia or bipolar disorder.
March 2013, Drugs of today (Barcelona, Spain : 1998),
Glenn W Currier
Inhaled Loxapine for ECT Pretreatment for Agitation.
June 2016, The journal of ECT,
Glenn W Currier
Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine.
February 2012, Bipolar disorders,
Glenn W Currier
Now take a deep breath: inhaled loxapine for the treatment of acute agitation.
January 2012, Journal of psychosocial nursing and mental health services,
Glenn W Currier
Inhaled Loxapine for Agitation in Intoxicated Patients: A Case Series.
January 2017, Clinical neuropharmacology,
Copied contents to your clipboard!